Sterling Investment Advisors, Ltd. Corcept Therapeutics Inc Transaction History

Sterling Investment Advisors, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$12.06 - $16.96 $120,600 - $169,600	-10,000 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$10.41 - $14.66 $41,640 - $58,640	4,000 Added 66.67%	10,000 $141,000
Q4 2018 Jan 18, 2019	BUY	$11.29 - $17.19 $22,580 - $34,380	2,000 Added 50.0%	6,000 $80,000
Q2 2018 Jul 26, 2018	BUY	$15.3 - $19.69 $15,300 - $19,690	1,000 Added 33.33%	4,000 $62,000
Q1 2018 Apr 23, 2018	BUY	$14.59 - $25.5 $43,770 - $76,500	3,000 New	3,000 $49,000

349

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.32B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.